LEADER 04061nam  22006495  450 
001 9910768197903321
005 20250805132449.0
010   $a9783031433566
010   $a3031433564
024 7 $a10.1007/978-3-031-43356-6
035   $a(MiAaPQ)EBC30983269
035   $a(Au-PeEL)EBL30983269
035   $a(OCoLC)1412622028
035   $a(CKB)29181435100041
035   $a(DE-He213)978-3-031-43356-6
035   $a(EXLCZ)9929181435100041
100   $a20231130d2023      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiomarkers in Neuropsychiatry $eA Primer /$fedited by Antonio L. Teixeira, Natalia P. Rocha, Michael Berk
205   $a1st ed. 2023.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2023.
215   $a1 online resource (363 pages)
311 08$aPrint version: Teixeira, Antonio L. Biomarkers in Neuropsychiatry Cham : Springer International Publishing AG,c2024 9783031433559 
320   $aIncludes bibliographical references and index.
327   $a1. Biomarkers in medicine and psychiatry: an overview -- 2 -- Genetic biomarkers of psychiatric disorders -- 3 -- Neurophysiological biomarkers -- 4 -- Structural neuroimaging biomarkers in psychiatry -- 5 -- Functional neuroimaging biomarkers -- 6 -- PET biomarkers in psychiatry -- 7 -- Digital markers of mental health problems: phenotyping across biological, psychological and environmental dimensions -- 8 -- Staging biomarkers in psychiatry -- 9 -- Biomarkers of delirium and cognitive impairment -- 10 -- Fluid-based biomarkers of Alzheimer?s disease -- 11 -- Neuroimaging biomarkers in Alzheimer?s disease and related disorders -- 12 -- Biomarkers of cognitive decline and dementia in Down?s syndrome -- 13 -- Biomarkers of schizophrenia -- 14 -- Biomarkers for bipolar disorder -- 15 -- Biomarkers in anxiety disorders -- 16 -- Biomarkers in obsessive-compulsive spectrum disorders -- 17 -- Sleep disorders: identifying biomarkers and clinical applications -- 18 -- Biomarkers in substance use disorders -- 19 -- Biomarkers of traumatic brain injury and related neuropsychiatric disorders -- 20 -- Biomarkers in psychiatry: conceptual and methodological challenges -- 21 -- Ethical issues related to biomarkers in psychiatry.
330   $aThis book presents the ?state of the art? of biomarkers research in neuropsychiatric conditions, from dementia to eating disorders, as well as providing methodological, practical and ethical issues related to the development of biomarkers. Biomarkers have revolutionized clinical research and practice in most fields of medicine, but psychiatry has lagged behind. However, in the last decade, there has been a growing expectation that biomarkers will advance and, ultimately, reframe psychiatry research and practice. Biomarkers might inform about diagnosis, therapeutics, prognosis, contributing to a ?personalized medicine?. Understanding their meaning, possibilities and limitations will help clinicians, researchers and students in the related areas navigate and excel in the challenging and ever changing field of neuropsychiatric disorders.
606   $aNeurosciences
606   $aPsychiatry
606   $aNeurology
606   $aPsychology
606   $aNeuroscience
606   $aPsychiatry
606   $aNeurology
606   $aBehavioral Sciences and Psychology
615  0$aNeurosciences.
615  0$aPsychiatry.
615  0$aNeurology.
615  0$aPsychology.
615 14$aNeuroscience.
615 24$aPsychiatry.
615 24$aNeurology.
615 24$aBehavioral Sciences and Psychology.
676   $a616.8
702   $aTeixeira$b Antonio L.
702   $aRocha$b Natalia P.
702   $aBerk$b Michael$c(College teacher)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910768197903321
996   $aBiomarkers in Neuropsychiatry$93656151
997   $aUNINA